Moreover, IL-26 upregulation has been found to be associated with reduced lung function, enhanced systemic inflammation, and upcoming exacerbations, suggesting a potent role in disease monitoring while serving as a biomarker of disease progression and exacerbation risk in patients with COPD. The gene discussed is IL26; the disease is chronic obstructive pulmonary disease.